J Michael Berry

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint A review of human papillomavirus vaccines: from basic science to clinical trials
    J Michael Berry
    University of California, San Francisco, Box 0512, 521 Parnassus Ave, San Francisco, CA 94143 0512, USA
    Front Biosci 8:s333-45. 2003
  2. ncbi request reprint Anal cancer and its precursors in HIV-positive patients: perspectives and management
    J Michael Berry
    General Clinical Research Center, University of California San Francisco School of Medicine, 505 Parnassus Avenue, Room M1203, Box 0126, San Francisco, CA 94143, USA
    Surg Oncol Clin N Am 13:355-73. 2004
  3. doi request reprint Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia
    J Michael Berry
    Department of Medicine, University of California San Francisco, San Francisco, California, USA
    Dis Colon Rectum 52:239-47. 2009
  4. ncbi request reprint A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals
    Joel M Palefsky
    Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    AIDS 20:1151-5. 2006
  5. doi request reprint Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with men
    Rachna Sharma
    Department of Medicine, University of California, San Francisco, San Francisco, CA Department of Public Health, East Carolina University Greenville, NC British Columbia Centre for Disease Control Public Health Microbiology and Reference Laboratory, BC Centre for Disease Control, Vancouver, British Columbia, Canada Department of Epidemiology and Biostatistics, University of California, San Francisco and Department of Pathology, University of California, San Francisco
    J Acquir Immune Defic Syndr 64:479-87. 2013
  6. ncbi request reprint Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men
    Peter V Chin-Hong
    University of California, San Francisco, Box 0654, 513 Parnassus Avenue, Room S 380, San Francisco, CA 94143 0654, USA
    Ann Intern Med 149:300-6. 2008
  7. doi request reprint Risk factors for anal human papillomavirus infection type 16 among HIV-positive men who have sex with men in San Francisco
    Alexandra L Hernandez
    Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA 94143, USA
    J Acquir Immune Defic Syndr 63:532-9. 2013
  8. ncbi request reprint Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men
    Joel M Palefsky
    Department of Medicine, University of California, San Francisco, California 94143, USA
    AIDS 19:1407-14. 2005
  9. ncbi request reprint Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSM
    Alexandra L Hernandez
    aDepartment of Medicine, University of California, San Francisco, San Francisco bSchool of Public Health, Department of Epidemiology, University of California, Berkeley, Berkeley, California cCenter for Health Disparities Research and Department of Public Health, Brody School of Medicine, Greenville, North Carolina dDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA
    AIDS 28:1341-9. 2014
  10. doi request reprint 32. HPV type and strain variant concordance between anal cancers and their preceding high-grade squamous intraepithelial lesions
    Joel Palefsky
    University of California, San Francisco, CA, USA
    Sex Health 10:585-6. 2013

Detail Information

Publications17

  1. ncbi request reprint A review of human papillomavirus vaccines: from basic science to clinical trials
    J Michael Berry
    University of California, San Francisco, Box 0512, 521 Parnassus Ave, San Francisco, CA 94143 0512, USA
    Front Biosci 8:s333-45. 2003
    ..All of the vaccines appear to be safe, well tolerated, and preliminary data indicates that most are clinically effective. Multiple trials are in progress and more mature data are expected within the next few years...
  2. ncbi request reprint Anal cancer and its precursors in HIV-positive patients: perspectives and management
    J Michael Berry
    General Clinical Research Center, University of California San Francisco School of Medicine, 505 Parnassus Avenue, Room M1203, Box 0126, San Francisco, CA 94143, USA
    Surg Oncol Clin N Am 13:355-73. 2004
    ....
  3. doi request reprint Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia
    J Michael Berry
    Department of Medicine, University of California San Francisco, San Francisco, California, USA
    Dis Colon Rectum 52:239-47. 2009
    ..High-resolution anoscopy with biopsy was used as the standard for detecting high-grade anal neoplasia and was compared to detection of high-grade anal neoplasia by anal cytology, human papillomavirus testing, or the combination...
  4. ncbi request reprint A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals
    Joel M Palefsky
    Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    AIDS 20:1151-5. 2006
    ....
  5. doi request reprint Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with men
    Rachna Sharma
    Department of Medicine, University of California, San Francisco, San Francisco, CA Department of Public Health, East Carolina University Greenville, NC British Columbia Centre for Disease Control Public Health Microbiology and Reference Laboratory, BC Centre for Disease Control, Vancouver, British Columbia, Canada Department of Epidemiology and Biostatistics, University of California, San Francisco and Department of Pathology, University of California, San Francisco
    J Acquir Immune Defic Syndr 64:479-87. 2013
    ..However, little is known about the prevalence of and risk factors for neutralizing antibody seropositivity to HPV-16 or HPV-18, a key measure of previous exposure to these types...
  6. ncbi request reprint Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men
    Peter V Chin-Hong
    University of California, San Francisco, Box 0654, 513 Parnassus Avenue, Room S 380, San Francisco, CA 94143 0654, USA
    Ann Intern Med 149:300-6. 2008
    ..Cytology screening can detect the anal cancer precursor, anal intraepithelial neoplasia (AIN). Little is known about self-collected samples for AIN screening, and few community-based AIN estimates exist...
  7. doi request reprint Risk factors for anal human papillomavirus infection type 16 among HIV-positive men who have sex with men in San Francisco
    Alexandra L Hernandez
    Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA 94143, USA
    J Acquir Immune Defic Syndr 63:532-9. 2013
    ..We determined the prevalence and risk factors for anal HPV 16 infection in a population of HIV-positive MSM, most of whom were being treated with antiretroviral therapy...
  8. ncbi request reprint Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men
    Joel M Palefsky
    Department of Medicine, University of California, San Francisco, California 94143, USA
    AIDS 19:1407-14. 2005
    ..We characterized the prevalence of AIN among HIV-positive MSM and examined the association between AIN and various factors including use of HAART...
  9. ncbi request reprint Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSM
    Alexandra L Hernandez
    aDepartment of Medicine, University of California, San Francisco, San Francisco bSchool of Public Health, Department of Epidemiology, University of California, Berkeley, Berkeley, California cCenter for Health Disparities Research and Department of Public Health, Brody School of Medicine, Greenville, North Carolina dDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA
    AIDS 28:1341-9. 2014
    ..The objective of this study was to determine the incidence of and risk factors for anal type-specific HPV infection...
  10. doi request reprint 32. HPV type and strain variant concordance between anal cancers and their preceding high-grade squamous intraepithelial lesions
    Joel Palefsky
    University of California, San Francisco, CA, USA
    Sex Health 10:585-6. 2013
    ..Two pairs contained the Eur-350G variant alone. Conclusions: Concordance of both the HPV type and strain variant in anal cancers and their site-matched preceding HSIL further supports the role of anal HSIL as an anal cancer precursor. ..
  11. ncbi request reprint Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study
    George J Chang
    Department of Surgery, University of California at San Francisco, San Francisco, California, USA
    Dis Colon Rectum 45:453-8. 2002
    ..We report the first prospective study of high-resolution anoscopy-directed surgical treatment of high-grade squamous intraepithelial lesions...
  12. ncbi request reprint Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study
    Elizabeth A Stier
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Acquir Immune Defic Syndr 47:56-61. 2008
    ..To evaluate prospectively the safety of the infrared coagulator (IRC) as a treatment for anal high-grade squamous intraepithelial lesions (HSILs) in HIV-infected individuals and to seek preliminary evidence for efficacy...
  13. ncbi request reprint Home study course: summer 2005
    J Michael Berry
    Division of Hematology Oncology, University of California San Francisco, CA, USA
    J Low Genit Tract Dis 9:182-7. 2005
    ..Credit is available for those who choose to apply. The Home Study Course is planned and produced in accordance with the ACCME's Essential Areas and Elements...
  14. ncbi request reprint Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men
    Ross D Cranston
    Department of Medicine, University of California at San Francisco, 94143, USA
    J Acquir Immune Defic Syndr 36:915-20. 2004
    ..Anal intraepithelial neoplasia (AIN) is common in men who have sex with men (MSM) and may be diagnosed by anal cytology screening...
  15. doi request reprint High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience
    Carlos E Pineda
    Department of General Surgery, Stanford University School of Medicine, Stanford, California, USA
    Dis Colon Rectum 51:829-35; discussion 835-7. 2008
    ....
  16. ncbi request reprint High resolution anoscopy and targeted treatment of high-grade squamous intraepithelial lesions
    Carlos E Pineda
    Facultad de Ciencias Medicas, Universidad San Carlos de Guatemala, Guatemala City, Guatemala
    Dis Colon Rectum 49:126. 2006
    ..The purpose of this video is to illustrate the use of high resolution anoscopy in the diagnosis and treatment of anal high-grade squamous intraepithelial lesions...
  17. ncbi request reprint High resolution anoscopy in the planned staged treatment of anal squamous intraepithelial lesions in HIV-negative patients
    Carlos E Pineda
    Department of Surgery, Stanford University School of Medicine, 300 Pasteur Drive, H3680F, Stanford, CA 94305 5655, USA
    J Gastrointest Surg 11:1410-5; discussion 1415-6. 2007
    ..Morbidity is minimal, and our progression to cancer rate is low (2.4%)...